首页> 外文期刊>Vascular pharmacology >Thyroid hormone and myocardial mitochondrial biogenesis
【24h】

Thyroid hormone and myocardial mitochondrial biogenesis

机译:甲状腺激素与心肌线粒体的生物发生

获取原文
获取原文并翻译 | 示例
           

摘要

Mitochondria have been central in the development of some of the most important ideas in modern biology. Since the discovery that mitochondria have its own DNA and specific mutations and deletions were found in association with neuromuscular and heart diseases, as well as in aging, an extraordinary number of publications have followed, and the term mitochondrial medicine was coined. Recently, it has been found that thyroid hormone (TH) stimulates cardiac mitochondrial biogenesis increasing myocardial mitochondrial mass, mitochondrial respiration, oxidative phosphorylation (OXPHOS), enzyme activities, mitochondrial protein synthesis (by stimulation in a T3-dependent manner), cytochrome, phospholipid and mtDNA content. Also, TH therapy may modulate cardiac mitochondrial protein-import apparatus. To identify the sequence of events, molecules and signaling pathways that is activated by TH affecting mitochondrial structure, biogenesis and function further research is warranted.
机译:线粒体一直是现代生物学中一些最重要的思想发展的中心。自从发现线粒体具有其自身的DNA并发现与神经肌肉疾病和心脏病以及衰老相关的特定突变和缺失后,随之而来的出版物数量非常多,因此创造了线粒体医学一词。最近,已发现甲状腺激素(TH)刺激心脏线粒体生物发生,从而增加心肌线粒体质量,线粒体呼吸,氧化磷酸化(OXPHOS),酶活性,线粒体蛋白质合成(通过T3依赖性方式刺激),细胞色素,磷脂和mtDNA含量。同样,TH疗法可能会调节心脏线粒体蛋白的导入设备。为了鉴定由TH激活的影响线粒体结构,生物发生和功能的事件,分子和信号通路的序列,有待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号